Aurora Cannabis sees 29% YoY growth and solid cash flow, unaffected by U.S. market fears. Read why ACB stock remains a solid ...

Shares of Aurora Cannabis Inc. ACB slid 1.05% to $4.73 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index COMP falling 0.09% to ...

Aurora Cannabis Inc (ACB) reports a 29% increase in net revenue, driven by a 93% surge in international medical cannabis ...

Shares of Canada-based Aurora Cannabis Inc. ($ACB) jumped more than 2% on Tuesday, ahead of the cannabis producer’s ...

Canadian medical marijuana giant Aurora Cannabis Inc. (NASDAQ:ACB) (TSX:ACB) reported its financial results Wednesday for the ...

Net income: CA$2.60m (up 40% from 2Q 2024). Profit margin: 3.2% (up from 2.9% in 2Q 2024). EPS: CA$0.05 (up from CA$0.048 in ...

Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) announced its financial results for the fiscal 2025 second quarter. Total revenue rose year-over-year and the company has a positive outlook for the ...

Aurora Cannabis (US) ( (ACB) ) has released its Q2 earnings. Here is a breakdown of the information Aurora Cannabis (US) presented to its ...

Down 99% from all-time highs, Aurora Cannabis stock is focused on improving profit margins and expanding sales of its medical ...

Aurora Cannabis (TSE:ACB) has released an update. Aurora Cannabis reported impressive fiscal 2025 second-quarter results, achieving a record ...

Aurora's international medical cannabis business bolstered its results, with European sales doubling quarter-over-quarter.

CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), a leading Canada-based global medical ...